The Multiplex Assays Market size is expected to grow at an annual average of 7% during 2021-2027. The multiplex assay is a procedure that simultaneously detects, quantifies, and profiles a variety of analytes (proteins, biomolecules, growth factors, cytokines, chemokines, etc.). This assay is used to amplify multiple targets in a polymerase chain reaction (PCR) and to collect more information from small amounts of proteins or other analytes in a shorter time compared to conventional methods such as ELISA. The multiplex analysis is widely used in pathogen identification, mutation analysis, RNA detection, gene detection analysis, linkage analysis, forensic research, etc.
(Get 15% Discount on Buying this Report)
A full report of Multiplex Assays Market is available at: https://www.orionmarketreports.com/multiplex-assays-market/53830/
The following segmentation are covered in this report:
By Application
- Companion Diagnostics
- Research & Development
- Clinical Diagnostics
By End User
- Hospitals
- Clinical Laboratories
- Research Institutes
- Pharmaceuticals & Biotechnological Companies
By Technology
- Multiplex PCR
- Multiplex Protein Microarray
- Others
Company Profile
- Abcam plc.
- Bio-Rad Laboratories, Inc.
- Biomerieux SA
- Hologic Corporation
- Luminex Corporation
- Merck KGaA
- Perkin Elmer Inc.
- Promega Corporation
- Quansys Biosciences Inc.
The report covers the following objectives:
- Proliferation and maturation of trade in the global Multiplex Assays Market
- The market share of the global Multiplex Assays Market supply and demand ratio, growth revenue, supply chain analysis, and business overview.
- Current and future market trends that are influencing the growth opportunities and growth rate of the Multiplex Assays Market
- Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Multiplex Assays Market
(This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.)
